Sensitivity and Specificity of the Roth Test in Patients With COVID-19 Positive

Completed

• Conditions: Covid19

• Registration Number: NCT04832828
• Lead Sponsor: Universidad Autonoma de Madrid

Brief Summary

The presence of the described silent hypoxia in subjects diagnosed with COVID19 highlights the need for valid tools to assess respiratory capacity. The Roth test has been associated with acceptable sensitivity and specificity criteria in patients with previous respiratory pathology; however, its validity in this type of patient has not been proven.

Detailed Description

Not available

Study Timeline

• Study Start: 2020-06-01
• Primary Completion: 2020-11-28
• Study Completion: 2020-11-28
• Study First Submitted: 2021-03-31
• Status Verified: 2021-04
• Study First Submitted QC: 2021-04-03
• Last Update Submitted: 2021-04-03
• Study First Posted: 2021-04-06
• Last Update Posted: 2021-04-06

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 114

Inclusion Criteria

1. having been diagnosed as COVID-19 positive and with symptoms compatible with Sars-Cov-2 infection in the last 7 days prior to assessment,
2. having an understanding of Spanish,
3. and having no history of respiratory pathology prior to the current infection.

Exclusion Criteria

Not provided

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Oxygen Saturation	12 weeks	The pulseoximeter percentage value

Secondary Outcome Measures

Name	Time	Method
Roth´s test	12 weeks	The level described in the test

Trial Locations

Locations (1)

CS Entrevías; 🇪🇸 Madrid, Spain